Lv1
90 积分 2024-08-06 加入
Development of [225Ac]Ac‑LNC1011 for targeted alpha-radionuclide therapy of prostate cancer
20天前
已完结
Dansylated Amino Acid–Modified Long-Acting PSMA Derivatives68Ga/177Lu-LNC1011 as Prostate Cancer Theranostics
20天前
已完结
Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial
1个月前
已完结
Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatment
1个月前
已完结
Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside
1个月前
已完结
The old CEACAMs find their new role in tumor immunotherapy
1个月前
已完结
Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer
1个月前
已完结
Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy
1个月前
已完结
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer
1个月前
已完结
Small molecule and peptide CXCR4 antagonists. A patent review from 2019 to 2024
1个月前
已完结
皖公网安备34019202002308
